US Stock MarketDetailed Quotes

GLMD Galmed Pharmaceuticals

Watchlist
  • 0.4000
  • +0.0386+10.68%
Close Apr 24 16:00 ET
  • 0.3899
  • -0.0101-2.53%
Post 19:35 ET
2.40MMarket Cap-160P/E (TTM)

Galmed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
66.83%-6.14M
77.68%-898K
30.09%-2.18M
76.87%-1.37M
68.91%-1.7M
43.75%-18.5M
42.43%-4.02M
65.34%-3.11M
22.54%-5.91M
41.29%-5.45M
Net income from continuing operations
61.31%-6.91M
23.61%-2.02M
72.47%-1.47M
57.34%-1.59M
70.21%-1.83M
44.97%-17.87M
64.59%-2.64M
30.65%-5.35M
55.53%-3.73M
31.02%-6.14M
Operating gains losses
-97.51%13K
-105.75%-44K
118.51%82K
-201.79%-57K
-77.93%32K
1,513.51%523K
15,400.00%765K
---443K
--56K
--145K
Depreciation and amortization
-11.43%31K
-33.33%6K
0.00%8K
0.00%9K
-11.11%8K
-16.67%35K
-10.00%9K
-27.27%8K
-10.00%9K
-18.18%9K
Other non cash items
-30.56%-47K
93.13%-32K
-99.36%3K
593.75%158K
-1,660.00%-176K
-376.92%-36K
-7,866.67%-466K
3,271.43%472K
-966.67%-32K
-150.00%-10K
Change In working capital
105.39%132K
154.68%993K
-152.24%-1.03M
107.59%202K
-161.02%-36K
-0.04%-2.45M
-2,489.47%-1.82M
206.50%1.97M
-1,337.21%-2.66M
106.59%59K
-Change in receivables
15.00%345K
-11.04%290K
20.11%-429K
-0.87%227K
-8.87%257K
195.85%300K
-40.62%326K
54.76%-537K
-22.90%229K
907.14%282K
-Change in payables and accrued expense
92.26%-213K
132.82%703K
-123.89%-598K
99.13%-25K
-31.39%-293K
-28.73%-2.75M
-352.85%-2.14M
479.82%2.5M
-3,423.17%-2.89M
75.84%-223K
Cash from discontinued investing activities
Operating cash flow
66.83%-6.14M
77.68%-898K
30.09%-2.18M
76.87%-1.37M
68.91%-1.7M
43.75%-18.5M
42.43%-4.02M
65.34%-3.11M
22.54%-5.91M
41.29%-5.45M
Investing cash flow
Cash flow from continuing investing activities
-95.44%800K
15.16%2.28M
-168.98%-3.54M
-83.01%705K
-78.59%1.35M
53.23%17.56M
-69.01%1.98M
12.59%5.13M
91.33%4.15M
483.76%6.31M
Net PPE purchase and sale
--0
--0
--0
----
----
63.64%-4K
0.00%-1K
--0
----
----
Net business purchase and sale
---1.5M
--0
--0
----
----
--0
--0
--0
----
----
Net investment purchase and sale
-86.91%2.3M
15.10%2.28M
-168.98%-3.54M
-46.91%2.21M
-78.59%1.35M
53.10%17.57M
134.85%1.98M
-69.17%5.13M
90.85%4.15M
483.99%6.31M
Cash from discontinued investing activities
Investing cash flow
-95.44%800K
15.16%2.28M
-168.98%-3.54M
-83.01%705K
-78.59%1.35M
53.23%17.56M
-69.01%1.98M
12.59%5.13M
91.33%4.15M
483.76%6.31M
Financing cash flow
Cash flow from continuing financing activities
8,735.71%6.19M
0
-99.60%70K
0
Net common stock issuance
8,735.71%6.19M
--0
----
----
----
-99.60%70K
--0
----
----
----
Proceeds from stock option exercised by employees
--0
----
----
----
----
--0
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
8,735.71%6.19M
--0
----
----
----
-99.60%70K
--0
----
----
----
Net cash flow
Beginning cash position
-28.95%2.13M
-61.75%1.6M
-46.32%1.12M
-53.67%1.79M
-28.95%2.13M
-57.54%3M
15.88%4.18M
-73.94%2.09M
-71.44%3.86M
-57.54%3M
Current changes in cash
197.70%848K
167.53%1.38M
-77.27%473K
62.41%-662K
-140.14%-344K
78.63%-868K
-238.02%-2.05M
146.94%2.08M
67.76%-1.76M
-86.69%857K
End cash Position
39.81%2.98M
39.81%2.98M
-61.75%1.6M
-46.32%1.12M
-53.67%1.79M
-28.95%2.13M
-28.95%2.13M
15.88%4.18M
-73.94%2.09M
-71.44%3.86M
Free cash flow
66.84%-6.14M
77.69%-898K
30.09%-2.18M
76.89%-1.37M
68.91%-1.7M
43.76%-18.51M
42.43%-4.03M
65.35%-3.11M
22.57%-5.91M
41.29%-5.45M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 66.83%-6.14M77.68%-898K30.09%-2.18M76.87%-1.37M68.91%-1.7M43.75%-18.5M42.43%-4.02M65.34%-3.11M22.54%-5.91M41.29%-5.45M
Net income from continuing operations 61.31%-6.91M23.61%-2.02M72.47%-1.47M57.34%-1.59M70.21%-1.83M44.97%-17.87M64.59%-2.64M30.65%-5.35M55.53%-3.73M31.02%-6.14M
Operating gains losses -97.51%13K-105.75%-44K118.51%82K-201.79%-57K-77.93%32K1,513.51%523K15,400.00%765K---443K--56K--145K
Depreciation and amortization -11.43%31K-33.33%6K0.00%8K0.00%9K-11.11%8K-16.67%35K-10.00%9K-27.27%8K-10.00%9K-18.18%9K
Other non cash items -30.56%-47K93.13%-32K-99.36%3K593.75%158K-1,660.00%-176K-376.92%-36K-7,866.67%-466K3,271.43%472K-966.67%-32K-150.00%-10K
Change In working capital 105.39%132K154.68%993K-152.24%-1.03M107.59%202K-161.02%-36K-0.04%-2.45M-2,489.47%-1.82M206.50%1.97M-1,337.21%-2.66M106.59%59K
-Change in receivables 15.00%345K-11.04%290K20.11%-429K-0.87%227K-8.87%257K195.85%300K-40.62%326K54.76%-537K-22.90%229K907.14%282K
-Change in payables and accrued expense 92.26%-213K132.82%703K-123.89%-598K99.13%-25K-31.39%-293K-28.73%-2.75M-352.85%-2.14M479.82%2.5M-3,423.17%-2.89M75.84%-223K
Cash from discontinued investing activities
Operating cash flow 66.83%-6.14M77.68%-898K30.09%-2.18M76.87%-1.37M68.91%-1.7M43.75%-18.5M42.43%-4.02M65.34%-3.11M22.54%-5.91M41.29%-5.45M
Investing cash flow
Cash flow from continuing investing activities -95.44%800K15.16%2.28M-168.98%-3.54M-83.01%705K-78.59%1.35M53.23%17.56M-69.01%1.98M12.59%5.13M91.33%4.15M483.76%6.31M
Net PPE purchase and sale --0--0--0--------63.64%-4K0.00%-1K--0--------
Net business purchase and sale ---1.5M--0--0----------0--0--0--------
Net investment purchase and sale -86.91%2.3M15.10%2.28M-168.98%-3.54M-46.91%2.21M-78.59%1.35M53.10%17.57M134.85%1.98M-69.17%5.13M90.85%4.15M483.99%6.31M
Cash from discontinued investing activities
Investing cash flow -95.44%800K15.16%2.28M-168.98%-3.54M-83.01%705K-78.59%1.35M53.23%17.56M-69.01%1.98M12.59%5.13M91.33%4.15M483.76%6.31M
Financing cash flow
Cash flow from continuing financing activities 8,735.71%6.19M0-99.60%70K0
Net common stock issuance 8,735.71%6.19M--0-------------99.60%70K--0------------
Proceeds from stock option exercised by employees --0------------------0----------------
Cash from discontinued financing activities
Financing cash flow 8,735.71%6.19M--0-------------99.60%70K--0------------
Net cash flow
Beginning cash position -28.95%2.13M-61.75%1.6M-46.32%1.12M-53.67%1.79M-28.95%2.13M-57.54%3M15.88%4.18M-73.94%2.09M-71.44%3.86M-57.54%3M
Current changes in cash 197.70%848K167.53%1.38M-77.27%473K62.41%-662K-140.14%-344K78.63%-868K-238.02%-2.05M146.94%2.08M67.76%-1.76M-86.69%857K
End cash Position 39.81%2.98M39.81%2.98M-61.75%1.6M-46.32%1.12M-53.67%1.79M-28.95%2.13M-28.95%2.13M15.88%4.18M-73.94%2.09M-71.44%3.86M
Free cash flow 66.84%-6.14M77.69%-898K30.09%-2.18M76.89%-1.37M68.91%-1.7M43.76%-18.51M42.43%-4.03M65.35%-3.11M22.57%-5.91M41.29%-5.45M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg